The hypereosinophilic syndromes: Current concepts and treatments

British Journal of Haematology

Volumn 145, Issue 3, 2009, Pages 271-285

  Gleich, Gerald J ^a   Leiferman, Kristin M ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Chronic eosinophilic leukaemia; Eosinophilia; FIP1L1 PDGFRA; Hypereosinophilic syndrome; Interleukin 5; Lymphocytic HES; Myeloproliferative HES

Indexed keywords

ALEMTUZUMAB; DASATINIB; EXEL 0862; GLUCOCORTICOID; HYDROXYUREA; IMATINIB; INFLIXIMAB; MEPOLIZUMAB; MIDOSTAURIN; NILOTINIB; PHOSPHOTRANSFERASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR A; PREDNISONE; RECOMBINANT ALPHA INTERFERON; RESLIZUMAB; SORAFENIB; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; ASSOCIATED HYPEREOSINOPHILIC SYNDROME; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; CHURG STRAUSS SYNDROME; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; CLONAL VARIATION; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; EDEMA; ENTERITIS; EOSINOPHILIA; FAMILIAL HYPEREOSINOPHILIC SYNDROME; FIP1L1 PDGFRA GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPEREOSINOPHILIC SYNDROME; KIT D816V GENE; LOW DRUG DOSE; LYMPHOCYTIC HYPEREOSINOPHILIC SYNDROME; MASTOCYTOSIS; MYELOPROLIFERATIVE DISORDER; MYELOPROLIFERATIVE HYPEREOSINOPHILIC SYNDROME; OVERLAP HYPEREOSINOPHILIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SARCOIDOSIS; SEX DIFFERENCE; SKIN DISEASE; T LYMPHOCYTE; UNDEFINED HYPEREOSINOPHILIC SYNDROME;

ANTINEOPLASTIC AGENTS; CLONE CELLS; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MUTATION; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PROGNOSIS; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; T-LYMPHOCYTES;

EID: 64149122012     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07599.x     Document Type: Review

References (117)

1. Ando, J., Sugimoto, K., Tamayose, K., Ando, M., Kojima, Y. Oshimi, K. (2007) Cytokine-producing sarcoma mimics eosinophilic leukaemia. European Journal of Haematology, 78, 169 170.
2. Ault, P., Cortes, J., Koller, C., Kaled, E.S. Kantarjian, H. (2002) Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. Leukemia Research, 26, 881 884.
3. Ault, P., Cortes, J., Lynn, A., Keating, M. Verstovsek, S. (2009) Pregnancy in a patient with hypereosinophilic syndrome. Leukemia Research, 33, 186 187.
4. Baccarani, M., Cilloni, D., Rondoni, M., Ottaviani, E., Messa, F., Merante, S., Tiribelli, M., Buccisano, F., Testoni, N., Gottardi, E., de Vivo, A., Giugliano, E., Iacobucci, I., Paolini, S., Soverini, S., Rosti, G., Rancati, F., Astolfi, C., Pane, F., Saglio, G. Martinelli, G. (2007) The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study. Haematologica, 92, 1173 1179.
5. Bae, S.Y., Yoon, S.Y., Huh, J.H., Sung, H.J. Choi, I.K. (2007) Hypereosinophilia in biphenotypic (B-cell/T-cell) acute lymphoblastic leukemia. Leukaemia & Lymphoma, 48, 1417 1419.
6. Bain, B.J. (1996) Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. British Journal of Haematology, 95, 2 9.
7. - helper type 2 (Th2) lymphocytes. Leukaemia & Lymphoma, 42, 123 133.
8. Barge, S., Bouchachi, A., Bechara, C., Lazure, T., Assayag, P. Lambotte, O. (2008) Eosinophilia with stroke in a Chinese patient: Kimura's disease complicated with fibroblastic endocarditis, first report. American Journal of Hematology, 83, 432.
9. Becker, V., Lersch, C., Gaa, J. Schmid, R.M. (2006) Partial Budd-Chiari syndrome associated with a hypereosinophilic syndrome. Zeitschrift fur Gastroenterologie, 44, 173 177.
10. Belongia, E.A., Hedberg, C.W., Gleich, G.J., White, K.E., Mayeno, A.N., Loegering, D.A., Dunnette, S.L., Pirie, P.L., MacDonald, K.L. Osterholm, M.T. (1990) An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. New England Journal of Medicine, 323, 357 365.
11. Blauwet, L.A., Breen, J.F., Edwards, W.D. Klarich, K.W. (2005) Atypical presentation of eosinophilic endomyocardial disease. Mayo Clinic Proceedings, 80, 1078 1084.
12. Bogenrieder, T., Griese, D.P., Schiffner, R., Buttner, R., Riegger, G.A., Hohenleutner, U. Landthaler, M. (1997) Wells' syndrome associated with idiopathic hypereosinophilic syndrome. British Journal of Dermatology, 137, 978 982.
13. Buitenhuis, M., Verhagen, L.P., Cools, J. Coffer, P.J. (2007) Molecular mechanisms underlying FIP1L1-PDGFRA-mediated myeloproliferation. Cancer Research, 67, 3759 3766.
14. Butterfield, J.H. (2001) Diverse clinical outcomes of eosinophilic patients with T-cell receptor gene rearrangements: the emerging diagnostic importance of molecular genetics testing. American Journal of Hematology, 68, 81 86.
15. Butterfield, J.H. (2007) Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon. Immunology and Allergy Clinics of North America, 27, 493 518.
16. Butterfield, J.H., Leiferman, K.M., Abrams, J., Silver, J.E., Bower, J., Gonchoroff, N. Gleich, G.J. (1992) Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood, 79, 688 692.
17. Butterfield, J.H., Leiferman, K.M. Gleich, G.J. (1993) Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clinical and Experimental Allergy, 23, 571 580.
18. Calux, M.J., Valente, N.Y., Pires, M.C. Albertoni Neto, D.R. (1988) Hypereosinophilic syndrome Cutaneous picture of "erythema annulare centrifugum"- comparison with ultrastructural study. Medicina Cutánea Ibero-Latino-Americana, 16, 299 304.
19. Capovilla, M., Cayuela, J.M., Bilhou-Nabera, C., Gardin, C., Letestu, R., Baran-Marzak, F., Fenaux, P. Martin, A. (2008) Synchronous FIP1L1-PDGFRA- positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancy. European Journal of Haematology, 80, 81 86.
20. Chikama, R., Hosokawa, M., Miyazawa, T., Miura, R., Suzuki, T. Tagami, H. (1998) Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan. Dermatology, 197, 321 325.
21. Chusid, M.J., Dale, D.C., West, B.C. Wolff, S.M. (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore), 54, 1 27.
22. Cilloni, D., Messa, F., Martinelli, G., Gottardi, E., Arruga, F., Defilippi, I., Carturan, S., Messa, E., Fava, M., Giugliano, E., Rosso, V., Catalano, R., Merante, S., Nicoli, P., Rondoni, M., Ottaviani, E., Soverini, S., Tiribelli, M., Pane, F., Baccarani, M. Saglio, G. (2007) WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia. Leukemia, 21, 1442 1450.
23. Cogan, E., Schandene, L., Crusiaux, A., Cochaux, P., Velu, T. Goldman, M. (1994) Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. New England Journal of Medicine, 330, 535 538.
24. Cools, J., DeAngelo, D.J., Gotlib, J., Stover, E.H., Legare, R.D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J.D., Cross, N.C., Tefferi, A., Malone, J., Alam, R., Schrier, S.L., Schmid, J., Rose, M., Vandenberghe, P., Verhoef, G., Boogaerts, M., Wlodarska, I., Kantarjian, H., Marynen, P., Coutre, S.E., Stone, R. Gilliland, D.G. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New England Journal of Medicine, 348, 1201 1214.
25. Cools, J., Stover, E.H. Gilliland, D.G. (2006) Detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia. Methods in Molecular Medicine, 125, 177 187.
26. Cortes, J., Ault, P., Koller, C., Thomas, D., Ferrajoli, A., Wierda, W., Rios, M.B., Letvak, L., Kaled, E.S. Kantarjian, H. (2003) Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood, 101, 4714 4716.
27. Curtis, C.E., Grand, F.H., Musto, P., Clark, A., Murphy, J., Perla, G., Minervini, M.M., Stewart, J., Reiter, A. Cross, N.C. (2007) Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia. British Journal of Haematology, 138, 77 81.
28. Dearden, C.E., Matutes, E. Catovsky, D. (2002) Alemtuzumab in T-cell malignancies. Medical Oncology, 19 (Suppl S27 S32.
29. Doorduijn, J.K., van Lom, K. Lowenberg, B. (1996) Eosinophilia and granulocytic dysplasia terminating in acute myeloid leukaemia after 24 years. British Journal of Haematology, 95, 531 534.
30. von Felbert, V., Simon, D., Braathen, L. Hunziker, T. (2006) Pemphigoid nodularis triggered by hypereosinophilic syndrome? Hautarzt, 57, 434 436.
31. Fletcher, S. Bain, B. (2007) Diagnosis and treatment of hypereosinophilic syndromes. Current Opinion in Hematology, 14, 37 42.
32. Fuzellier, J.F., Chapoutot, L., Torossian, P.F., Metz, D. Baehrel, B. (2005) Mitral valve replacement in idiopathic eosinophilic endocarditis without peripheral eosinophilia. Journal of Cardiac Surgery, 20, 472 474.
33. Ghia, P., Prato, G., Stella, S., Scielzo, C., Geuna, M. Caligaris-Cappio, F. (2007) Age-dependent accumulation of monoclonal CD4+CD8+ double positive T lymphocytes in the peripheral blood of the elderly. British Journal of Haematology, 139, 780 790.
34. Gleich, G.J., Schroeter, A.L., Marcoux, J.P., Sachs, M.I., O'Connell, E.J. Kohler, P.F. (1984) Episodic angioedema associated with eosinophilia. New England Journal of Medicine, 310, 1621 1626.
35. Gleich, G.J., Leiferman, K.M., Pardanani, A., Tefferi, A. Butterfield, J.H. (2002) Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet, 359, 1577 1578.
36. Granjo, E., Lima, M., Lopes, J.M., Doria, S., Orfao, A., Ying, S., Barata, L.T., Miranda, M., Cross, N.C. Bain, B.J. (2002) Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case report. Acta Haematologica, 107, 108 112.
37. Griffin, J.H., Leung, J., Bruner, R.J., Caligiuri, M.A. Briesewitz, R. (2003) Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 100, 7830 7835.
38. Hardy, W.R. Anderson, R.E. (1968) The hypereosinophilic syndromes. Annals of Internal Medicine, 68, 1220 1229.
39. Helbig, G., Stella-Holowiecka, B., Majewski, M., Calbecka, M., Gajkowska, J., Klimkiewicz, R., Moskwa, A., Grzegorczyk, J., Lewandowska, M. Holowiecki, J. (2008) A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients. British Journal of Haematology, 141, 200 204.
40. Hertzman, P.A., Blevins, W.L., Mayer, J., Greenfield, B., Ting, M. Gleich, G.J. (1990) Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. New England Journal of Medicine, 322, 869 873.
41. van den Hoogenband, H.M. (1982) Skin lesions as the first manifestation of the hypereosinophilic syndrome. Clinical and Experimental Dermatology, 7, 267 271.
42. Inoue, A., Michitaka, K., Shigematsu, S., Konishi, I., Hirooka, M., Hiasa, Y., Matsui, H., Matsuura, B., Horiike, N., Hato, T., Miyaoka, H. Onji, M. (2007) Budd-Chiari syndrome associated with hypereosinophilic syndrome; a case report. Internal Medicine, 46, 1095 1100.
43. Jang, K.A., Lim, Y.S., Choi, J.H., Sung, K.J., Moon, K.C. Koh, J.K. (2000) Hypereosinophilic syndrome presenting as cutaneous necrotizing eosinophilic vasculitis and Raynaud's phenomenon complicated by digital gangrene. British Journal of Dermatology, 143, 641 644.
44. Jang, J.S., Kim, C.H., Kim, S.S., Oh, J.E., Park, Y.B., Lee, J.Y. Mo, E.K. (2006) A case report of nonepisodic angioedema with eosinophilia in a Korean patient and a review of the Korean literature. Korean Journal of Internal Medicine, 21, 275 278.
45. Jovanovic, J.V., Score, J., Waghorn, K., Cilloni, D., Gottardi, E., Metzgeroth, G., Erben, P., Popp, H., Walz, C., Hochhaus, A., Roche-Lestienne, C., Preudhomme, C., Solomon, E., Apperley, J., Rondoni, M., Ottaviani, E., Martinelli, G., Brito-Babapulle, F., Saglio, G., Hehlmann, R., Cross, N.C., Reiter, A. Grimwade, D. (2007) Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood, 109, 4635 4640.
46. Kalac, M., Quintas-Cardama, A., Vrhovac, R., Kantarjian, H. Verstovsek, S. (2007) A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia. Cancer, 110, 955 964.
47. Kawata, E., Kuroda, J., Wada, K., Yoshida, M., Kamiuchi, K., Nakayama-Harusato, I., Kimura, S., Maekawa, T. Kitagawa, Y. (2007) Hypereosinophilic syndrome accompanied by Buerger's disease-like femoral arterial occlusions. Internal Medicine, 46, 1919 1922.
48. Kazmierowski, J.A., Chusid, M.J., Parrillo, J.E., Fauci, A.S. Wolff, S.M. (1978) Dermatologic manifestations of the hypereosinophilic syndrome. Archives of Dermatology, 114, 531 535.
49. Kilbourne, E.M., Rigau-Perez, J.G., Heath, C.W. Jr., Zack, M.M., Falk, H., Martin-Marcos, M. de Carlos, A. (1983) Clinical epidemiology of toxic-oil syndrome. Manifestations of a New Illness. New England Journal of Medicine, 309, 408 414.
50. Kitano, K., Ichikawa, N., Shimodaira, S., Ito, T., Ishida, F. Kiyosawa, K. (1997) Eosinophilia associated with clonal T-cell proliferation. Leukaemia & Lymphoma, 27, 335 342.
51. Klion, A.D., Noel, P., Akin, C., Law, M.A., Gilliland, D.G., Cools, J., Metcalfe, D.D. Nutman, T.B. (2003) Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood, 101, 4660 4666.
52. Klion, A.D., Law, M.A., Noel, P., Kim, Y.J., Haverty, T.P. Nutman, T.B. (2004) Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood, 103, 2939 2941.
53. Klion, A.D., Bochner, B.S., Gleich, G.J., Nutman, T.B., Rothenberg, M.E., Simon, H.U., Wechsler, M.E., Weller, P.F. The Hypereosinophilic Syndromes Working, G. (2006) Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. Journal of Allergy and Clinical Immunology, 117, 1292 1302.
54. Klion, A.D., Robyn, J., Maric, I., Fu, W., Schmid, L., Lemery, S., Noel, P., Law, M.A., Hartsell, M., Talar-Williams, C., Fay, M.P., Dunbar, C.E. Nutman, T.B. (2007) Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing. Blood, 110, 3552 3556.
55. Kuk, J.S., Maceachern, J.A., Soamboonsrup, P., McFarlane, A., Benger, A., Patterson, W., Yang, L. Trus, M.R. (2006) Chronic eosinophilic leukemia presenting with autoimmune hemolytic anemia and erythrophagocytosis by eosinophils. American Journal of Hematology, 81, 458 461.
56. de Lavareille, A., Roufosse, F., Schmid-Grendelmeier, P., Roumier, A.S., Schandene, L., Cogan, E., Simon, H.U. Goldman, M. (2002) High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. Journal of Allergy and Clinical Immunology, 110, 476 479.
57. Lee, C.H., Mamelak, A.J. Vonderheid, E.C. (2007) Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis. International Journal of Dermatology, 46, 1198 1204.
58. Leiferman, K.M. Gleich, G.J. (2004) Hypereosinophilic syndrome: case presentation and update. Journal of Allergy and Clinical Immunology, 113, 50 58.
59. Leiferman, K.M., O'Duffy, J.D., Perry, H.O., Greipp, P.R., Giuliani, E.R. Gleich, G.J. (1982) Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. Journal of The American Medical Association, 247, 1018 1020.
60. Leiferman, K.M., Ackerman, S.J., Sampson, H.A., Haugen, H.S., Venencie, P.Y. Gleich, G.J. (1985) Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. New England Journal of Medicine, 313, 282 285.
61. Leiferman, K.M., Gleich, G.J. Peters, M.S. (2007) Dermatologic manifestations of the hypereosinophilic syndromes. Immunology and Allergy Clinics of North America, 27, 415 441.
62. Liao, Y.H., Su, Y.W., Tsay, W. Chiu, H.C. (2005) Association of cutaneous necrotizing eosinophilic vasculitis and deep vein thrombosis in hypereosinophilic syndrome. Archives of Dermatology, 141, 1051 1053.
63. Lierman, E., Folens, C., Stover, E.H., Mentens, N., Van Miegroet, H., Scheers, W., Boogaerts, M., Vandenberghe, P., Marynen, P. Cools, J. (2006) Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant. Blood, 108, 1374 1376.
64. Lin, A.Y., Nutman, T.B., Kaslow, D., Mulvihill, J.J., Fontaine, L., White, B.J., Knutsen, T., Theil, K.S., Raghuprasad, P.K., Goldstein, A.M. Tucker, M.A. (1998) Familial eosinophilia: clinical and laboratory results on a U.S. kindred. American Journal of Medical Genetics, 76, 229 237.
65. Lincoff, N.S. Schlesinger, D. (2005) Recurrent optic neuritis as the presenting manifestation of primary hypereosinophilic syndrome: a report of two cases. Journal of Neuro-Ophthalmology, 25, 116 121.
66. Maric, I., Robyn, J., Metcalfe, D.D., Fay, M.P., Carter, M., Wilson, T., Fu, W., Stoddard, J., Scott, L., Hartsell, M., Kirshenbaum, A., Akin, C., Nutman, T.B., Noel, P. Klion, A.D. (2007) KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. Journal of Allergy and Clinical Immunology, 120, 680 687.
67. McMillan, H.J., Johnston, D.L. Doja, A. (2008) Watershed infarction due to acute hypereosinophilia. Neurology, 70, 80 82.
68. Miljkovic, J. Bartenjev, I. (2005) Hypereosinophilic dermatitis-like erythema annulare centrifugum in a patient with chronic lymphocytic leukaemia. Journal of the European Academy of Dermatology and Venereology, 19, 228 231.
69. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. Coffman, R.L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology, 136, 2348 2357.
70. Naiman, J.L., Oski, F.A., Allen, F.H., Jr. Diamond, L.K. (1964) Hereditary Eosinophilia: Report of a Family and Review of the Literature. American Journal of Human Genetics, 16, 195 203.
71. Ng, H.J., Tan, D.C., Yiu, R.C. How, G.F. (2008) Maintenance therapy with imatinib appears necessary despite molecular remission in FIP1L1-PDGFRA fusion gene positive hypereosinophilic disorder. Leukemia Research, 32, 169 171.
72. Ogasa, M., Nakamura, Y., Sanai, H. Ueda, K. (2006) A case of pregnancy associated hypereosinophilia with hyperpermeability symptoms. Gynecologic and Obstetric Investigation, 62, 14 16.
73. Ogbogu, P.U., Rosing, D.R. Horne, M.K., 3rd. 2007) Cardiovascular manifestations of hypereosinophilic syndromes. Immunology and Allergy Clinics of North America, 27, 457 475.
74. Ohtani, T., Okamoto, K., Kaminaka, C., Kishi, T., Sakurane, M., Yamamoto, Y., Uede, K., Kubo, K., Kuroyanagi, Y. Furukawa, F. (2004) Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS). European Journal of Dermatology, 14, 168 171.
75. Pan, J., Quintas-Cardama, A., Manshouri, T., Giles, F.J., Lamb, P., Tefferi, A., Cortes, J., Kantarjian, H. Verstovsek, S. (2007) The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha- expressing cells through caspase-3-mediated cleavage of Mcl-1. Leukemia, 21, 1395 1404.
76. Pardanani, A., Ketterling, R.P., Brockman, S.R., Flynn, H.C., Paternoster, S.F., Shearer, B.M., Reeder, T.L., Li, C.Y., Cross, N.C., Cools, J., Gilliland, D.G., Dewald, G.W. Tefferi, A. (2003a) CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood, 102, 3093 3096.
77. Pardanani, A., Elliott, M., Reeder, T., Li, C.Y., Baxter, E.J., Cross, N.C. Tefferi, A. (2003b) Imatinib for systemic mast-cell disease. Lancet, 362, 535 536.
78. Pardanani, A., Reeder, T., Porrata, L.F., Li, C.Y., Tazelaar, H.D., Baxter, E.J., Witzig, T.E., Cross, N.C. Tefferi, A. (2003c) Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood, 101, 3391 3397.
79. Pardanani, A., Brockman, S.R., Paternoster, S.F., Flynn, H.C., Ketterling, R.P., Lasho, T.L., Ho, C.L., Li, C.Y., Dewald, G.W. Tefferi, A. (2004) FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood, 104, 3038 3045.
80. Pardanani, A., Ketterling, R.P., Li, C.Y., Patnaik, M.M., Wolanskyj, A.P., Elliott, M.A., Camoriano, J.K., Butterfield, J.H., Dewald, G.W. Tefferi, A. (2006) FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leukemia Research, 30, 965 970.
81. Pitini, V., Teti, D., Arrigo, C. Righi, M. (2004) Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report. British Journal of Haematology, 127, 477.
82. Ponsky, T.A., Brody, F., Giordano, J., Garcia, R., Kardon, D. Schwartz, A. (2005) Brachial artery occlusion secondary to hypereosinophilic syndrome. Journal of Vascular Surgery, 42, 796 799.
83. Rioux, J.D., Stone, V.A., Daly, M.J., Cargill, M., Green, T., Nguyen, H., Nutman, T., Zimmerman, P.A., Tucker, M.A., Hudson, T., Goldstein, A.M., Lander, E. Lin, A.Y. (1998) Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. American Journal of Human Genetics, 63, 1086 1094.
84. Robyn, J., Lemery, S., McCoy, J.P., Kubofcik, J., Kim, Y.J., Pack, S., Nutman, T.B., Dunbar, C. Klion, A.D. (2006) Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome. British Journal of Haematology, 132, 286 292.
85. Roche-Lestienne, C., Lepers, S., Soenen-Cornu, V., Kahn, J.E., Lai, J.L., Hachulla, E., Drupt, F., Demarty, A.L., Roumier, A.S., Gardembas, M., Dib, M., Philippe, N., Cambier, N., Barete, S., Libersa, C., Bletry, O., Hatron, P.Y., Quesnel, B., Rose, C., Maloum, K., Blanchet, O., Fenaux, P., Prin, L. Preudhomme, C. (2005) Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia, 19, 792 798.
86. Romagnani, S. (1996) Th1 and Th2 in human diseases. Clinical Immunology and Immunopathology, 80, 225 235.
87. Rothenberg, M.E., Klion, A.D., Roufosse, F.E., Kahn, J.E., Weller, P.F., Simon, H.U., Schwartz, L.B., Rosenwasser, L.J., Ring, J., Griffin, E.F., Haig, A.E., Frewer, P.I., Parkin, J.M. Gleich, G.J. (2008) Treatment of patients with the hypereosinophilic syndrome with mepolizumab. New England Journal of Medicine, 358, 1215 1228.
88. Roufosse, F., Cogan, E. Goldman, M. (2007) Lymphocytic variant hypereosinophilic syndromes. Immunology and Allergy Clinics of North America, 27, 389 413.
89. Sada, A., Katayama, Y., Yamamoto, K., Okuyama, S., Nakata, H., Shimada, H., Oshimi, K., Mori, M. Matsui, T. (2007) A multicenter analysis of the FIP1L1-alphaPDGFR fusion gene in Japanese idiopathic hypereosinophilic syndrome: an aberrant splicing skipping the alphaPDGFR exon 12. Annals of Hematology, 86, 855 863.
90. Sakuta, R., Tomita, Y., Ohashi, M., Nagai, T. Murakami, N. (2007) Idiopathic hypereosinophilic syndrome complicated by central sinovenous thrombosis. Brain and Development, 29, 182 184.
91. Sanderson, C.J., Campbell, H.D. Young, I.G. (1988) Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunological Reviews, 102, 29 50.
92. Schandene, L., Roufosse, F., de Lavareille, A., Stordeur, P., Efira, A., Kennes, B., Cogan, E. Goldman, M. (2000) Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood, 96, 4285 4292.
93. Schrezenmeier, H., Thome, S.D., Tewald, F., Fleischer, B. Raghavachar, A. (1993) Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Experimental Hematology, 21, 358 365.
94. Sefcick, A., Sowter, D., DasGupta, E., Russell, N.H. Byrne, J.L. (2004) Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome. British Journal of Haematology, 124, 558 559.
95. Sheikh, J. Weller, P.F. (2007) Clinical overview of hypereosinophilic syndromes. Immunology and Allergy Clinics of North America, 27, 333 355.
96. Shelley, W.B. Shelley, E.D. (1985) Erythema annulare centrifugum as the presenting sign of the hypereosinophilic syndrome: observations on therapy. Cutis, 35, 53 55.
97. Simon, D. Simon, H.U. (2007) Eosinophilic disorders. Journal of Allergy and Clinical Immunology, 119, 1291 1300.
98. Simon, H.U., Yousefi, S., Dommann-Scherrer, C.C., Zimmermann, D.R., Bauer, S., Barandun, J. Blaser, K. (1996) Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. Journal of Experimental Medicine, 183, 1071 1082.
99. Simon, H.U., Plotz, S.G., Dummer, R. Blaser, K. (1999) Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. New England Journal of Medicine, 341, 1112 1120.
100. Simon, D., Salemi, S., Yousefi, S. Simon, H.U. (2008) Primary resistance to imatinib in Fip1-like 1-platelet-derived growth factor receptor alpha-positive eosinophilic leukemia. Journal of Allergy and Clinical Immunology, 121, 1054 1056.
101. Solley, G.O., Maldonado, J.E., Gleich, G.J., Giuliani, E.R., Hoagland, H.C., Pierre, R.V. Brown, A.L., Jr. (1976) Endomyocardiopathy with eosinophilia. Mayo Clinic Proceedings, 51, 697 708.
102. Songsiridej, V., Peters, M.S., Dor, P.J., Ackerman, S.J., Gleich, G.J. Busse, W.W. (1985) Facial edema and eosinophilia. Evidence for eosinophil degranulation. Annals of Internal Medicine, 103, 503 506.
103. Takatsu, K., Tominaga, A., Harada, N., Mita, S., Matsumoto, M., Takahashi, T., Kikuchi, Y. Yamaguchi, N. (1988) T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunological Reviews, 102, 107 135.
104. Talley, N.J., Kephart, G.M., McGovern, T.W., Carpenter, H.A. Gleich, G.J. (1992) Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology, 103, 137 145.
105. Taverna, J.A., Lerner, A., Goldberg, L., Werth, S. Demierre, M.F. (2007) Infliximab as a therapy for idiopathic hypereosinophilic syndrome. Archives of Dermatology, 143, 1110 1112.
106. Tefferi, A. Vardiman, J.W. (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22, 14 22.
107. Terrier, B., Piette, A.M., Kerob, D., Cordoliani, F., Tancrede, E., Hamidou, L., Lebbe, C., Bletry, O. Kahn, J.E. (2006) Superficial venous thrombophlebitis as the initial manifestation of hypereosinophilic syndrome: study of the first 3 cases. Archives of Dermatology, 142, 1606 1610.
108. Tsuji, Y., Kawashima, T., Yokota, K., Tateishi, Y., Kobayashi, H., Itoh, A. Shimizu, H. (2002) Wells' syndrome as a manifestation of hypereosinophilic syndrome. British Journal of Dermatology, 147, 811 812.
109. Vaklavas, C., Tefferi, A., Butterfield, J., Ketterling, R., Verstovsek, S., Kantarjian, H. Pardanani, A. (2007) 'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical course. Leukemia Research, 31, 691 694.
110. Vigna, E., Lucia, E., Gentile, M., Mazzone, C., Bisconte, M.G., Gentile, C., Armentano, A., Ottaviani, E., Rondoni, M., Martinelli, G. Morabito, F. (2008) PDGFRalpha/FIP1L1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment. Cancer Chemotherapy and Pharmacology, 61, 713 716.
111. Wagner, L.A., Speckart, S., Cutter, B.A. Gleich, G.J. (2009) Treatment of FIP1L1/PDFGRA negative hypereosinophilic syndrome by alemtuzumab, an anti-CD52 antibody. Journal of Allergy and Clinical Immunology in press).
112. Wechsler, M.E. (2007) Pulmonary eosinophilic syndromes. Immunology and Allergy Clinics of North America, 27, 477 492.
113. Weller, P.F. Bubley, G.J. (1994) The idiopathic hypereosinophilic syndrome. Blood, 83, 2759 2779.
114. Willard-Gallo, K.E., Badran, B.M., Ravoet, M., Zerghe, A., Burny, A., Martiat, P., Goldman, M., Roufosse, F. Sibille, C. (2005) Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome. Experimental Hematology, 33, 1147 1159.
115. Yoo, T.J., Orman, S.V., Patil, S.R., Dorminey, C., Needleman, S., Rajtora, D., Graves, N., Ackerman, L. Taylor, W.W. (1984) Evolution to eosinophilic leukemia with a t(5:11) translocation in a patient with idiopathic hypereosinophilic syndrome. Cancer Genetics and Cytogenetics, 11, 389 384.
116. Zenone, T. Ligeon-Ligeonnet, P. (2005) Hypereosinophilic syndrome and orbital inflammatory pseudotumor. Presse Medicale, 34, 1141 1142.
117. Zuo, L. Rothenberg, M.E. (2007) Gastrointestinal eosinophilia. Immunology and Allergy Clinics of North America, 27, 443 455.